|
Free Research Articles
Citations 311-320 of 789 total displayed.
|
Past content
(since May 2004):
|
Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies
- Reinhard Marks, Karin Potthoff, Joachim Hahn, Gabriele Ihorst, Hartmut Bertz, Alexandros Spyridonidis, Ernst Holler, and Jürgen M. Finke
Blood 2008; 112: 415-425.
[Abstract]
[Full text]
[PDF]
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission
- David I. Marks, Waleska S. Pérez, Wensheng He, Mei-Jie Zhang, Michael R. Bishop, Brian J. Bolwell, Christopher N. Bredeson, Edward A. Copelan, Robert Peter Gale, Vikas Gupta, Gregory A. Hale, Luis M. Isola, Ann A. Jakubowski, Armand Keating, Thomas R. Klumpp, Hillard M. Lazarus, Jane L. Liesveld, Richard T. Maziarz, Philip L. McCarthy, Mitchell Sabloff, Gary Schiller, Jorge Sierra, Martin S. Tallman, Edmund K. Waller, Peter H. Wiernik, and Daniel J. Weisdorf
Blood 2008; 112: 426-434.
[Abstract]
[Full text]
[PDF]
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
- J. Evan Sadler
Blood 2008; 112: 11-18.
[Abstract]
[Full text]
[PDF]
Advances in understanding pathogenic mechanisms of thrombophilic disorders
- Björn Dahlbäck
Blood 2008; 112: 19-27.
[Abstract]
[Full text]
[PDF]
Investment analysts and the American Society of Hematology
- David P. Steensma
Blood 2008; 112: 29-33.
[Abstract]
[Full text]
[PDF]
Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- Dana E. Rollison, Nadia Howlader, Martyn T. Smith, Sara S. Strom, William D. Merritt, Lynn A. Ries, Brenda K. Edwards, and Alan F. List
Blood 2008; 112: 45-52.
[Abstract]
[Full text]
[PDF]
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy
- Elias Jabbour, Hagop Kantarjian, Dan Jones, Megan Breeden, Guillermo Garcia-Manero, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, and Jorge Cortes
Blood 2008; 112: 53-55.
[Abstract]
[Full text]
[PDF]
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- Philip A. Beer, Peter J. Campbell, Linda M. Scott, Anthony J. Bench, Wendy N. Erber, David Bareford, Bridget S. Wilkins, John T. Reilly, Hans C. Hasselbalch, Richard Bowman, Keith Wheatley, Georgina Buck, Claire N. Harrison, and Anthony R. Green
Blood 2008; 112: 141-149.
[Abstract]
[Full text]
[PDF]
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia
- Fu Jun Li, Shouluan Ding, Jicun Pan, Mikhail A. Shakhmatov, Elena Kashentseva, Jiongru Wu, Yufeng Li, Seng-jaw Soong, Nicholas Chiorazzi, and Randall S. Davis
Blood 2008; 112: 179-187.
[Abstract]
[Full text]
[PDF]
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis
- Nancy Berliner
Blood 2008; 111: 5427-5432.
[Abstract]
[Full text]
[PDF]
|
|
